Fingerprint
Dive into the research topics of 'Cefixime allows greater dose escalation of oral irinotecan: A phase I study in pediatric patients with refractory solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cefixime allows greater dose escalation of oral irinotecan: A phase I study in pediatric patients with refractory solid tumors
Wayne L. Furman, Kristine R. Crews, Catherine Billups, Jianrong Wu, Amar J. Gajjar, Najat C. Daw, Christian C. Patrick, Carlos Rodriguez-Galindo, Clinton F. Stewart, Jeffrey S. Dome, John C. Panetta, Peter J. Houghton, Victor M. Santana
Research output: Contribution to journal › Article › peer-review
60
Scopus
citations